Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Presentations

Corporate Presentation - January 2020

Download the Presentation

LPCN 1144 Presentation

Download the Presentation